Evidence map›Paper›PMID 40259232›Full record

ArticleBMC infectious diseases2025

A machine learning model for predicting severe mycoplasma pneumoniae pneumonia in school-aged children.

Yingying Ye, Zhenpeng Gao, Zhiling Zhang, Jianlong Chen, Chu Chu, Weifang Zhou

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Machine learning-based prediction models for severeFrontiers in public health · 2026
    Pooled it
  2. Trial
  3. Mapping the Evolution of Diagnostic Research onPathogens (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Nomogram to predict severeFrontiers in pediatrics · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingying YeDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China.
Zhenpeng GaoDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China.
Zhiling ZhangDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China.
Jianlong ChenDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China.
Chu ChuDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China. szdxchuchu@163.com.
Weifang ZhouDepartment of Infectious Diseases, Children's Hospital of Soochow University, No. 303, Jingde Road, Suzhou, China. zwf_1969@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop an interpretable machine learning (ML) model for predicting severe Mycoplasma pneumoniae pneumonia (SMPP) in order to provide reliable factors for predicting the clinical type of the disease.

methodsWe collected clinical data from 483 school-aged children with M. pneumoniae pneumonia (MPP) who were hospitalized at the Children's Hospital of Soochow University between September 2021 and June 2024. Difference analysis and univariate logistic regression were employed to identify predictors for training features in ML. Eight ML algorithms were used to build models based on the selected features, and their effectiveness was validated. The area under the curve (AUC), accuracy, five-fold cross-validation, and decision curve analysis (DCA) were utilized to evaluate model performance. Finally, the best-performing ML model was selected, and the Shapley Additive Explanations (SHAP) method was applied to rank the importance of clinical features and interpret the final model.

resultsAfter feature selection, 30 variables remained. We constructed eight ML models and assessed their effectiveness, finding that the CatBoost model exhibited the best predictive performance, with an AUC of 0.934 and an accuracy of 0.9175. DCA was used to compare the clinical benefits of the models, revealing that the CatBoost model provided greater net benefits than the other ML models within the threshold probability range of 34% to 75%. Additionally, we applied the SHAP method to interpret the CatBoost model, and the SHAP diagram was used to visually show the influence of predictor variables on the outcome. The results identified the top six risk factors as the number of days with fever, D-dimer, platelet count (PLT), C-reactive protein (CRP), lactate dehydrogenase (LDH), and the neutrophil-to-lymphocyte ratio (NLR).

conclusionsThe interpretable CatBoost model can help physicians accurately identify school-aged children with SMPP. This early identification facilitates better treatment options and timely prevention of complications. Furthermore, the SHAP algorithm enhances the model's transparency and increases its trustworthiness in practical applications.

Indexed as

Machine LearningMycoplasma pneumoniaePneumonia, MycoplasmaAlgorithmsChildFemaleHumansMaleCatBoostMachine learningMycoplasma pneumoniae pneumoniaSchool-aged children

Identifiers

PMID40259232
PMCPMC12013137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.